Search

Your search keyword '"Messina, Nicole L."' showing total 139 results

Search Constraints

Start Over You searched for: Author "Messina, Nicole L." Remove constraint Author: "Messina, Nicole L." Language english Remove constraint Language: english
139 results on '"Messina, Nicole L."'

Search Results

2. Accelerated Bacille Calmette-Guérin reactions: More than meets the eye

3. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial

7. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial

8. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

9. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines

10. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination

11. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines

13. Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled Trial.

14. Inappropriate prescribing contributes to high antibiotic exposure in young children in Australia.

19. Factors influencing adverse events following COVID-19 vaccination.

21. Interpreting the Results of Trials of BCG Vaccination for Protection Against COVID-19.

23. Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination.

24. The association between the composition of the early-life intestinal microbiome and eczema in the first year of life.

25. An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

26. Safety of BCG vaccination and revaccination in healthcare workers.

27. Correlation of Vaccine Responses

28. The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.

29. Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19.

30. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Analysis of a Randomized Controlled Trial.

31. Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial.

36. Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled Trial.

39. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.

40. The impact of human single nucleotide polymorphisms on Bacillus Calmette-Guérin responses.

41. Neonatal BCG Vaccination Reduces Interferon-γ Responsiveness to Heterologous Pathogens in Infants From a Randomized Controlled Trial.

43. Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.

44. THE AUTHORS REPLY.

45. 314Data-adaptive methods for high-dimensional mediation analysis: Application to a randomised trial of tuberculosis vaccination.

46. NF-κB control of T cell development.

47. Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1.

49. Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

50. Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.

Catalog

Books, media, physical & digital resources